Describe the prevalence and implications of inadequately treated depression and the importance of fully treating depressive symptoms Assess the MOAs of FDA-approved and emerging AAPs to address inadequately treated MDD Evaluate the latest efficacy, safety, and tolerability data associated with FDA-approved and emerging AAPs for inadequately treated MDD Implement strategies to optimize appropriate utilization of AAPs for depression, including considerations for initial selection and treatment switching and mitigation of AEs
- Provider:HMP Education
- Activity Link: https://hmpeducation.com/program/24-uspc-101-20
- Start Date: 2024-12-16 06:00:00
- End Date: 2024-12-16 06:00:00
- Credit Details: AAPA Category 1 Credit™️: 1.25 hours
AMA PRA Category 1 Credit™️: 1.25 hours
Nursing: 1.25 hours
Pharmacy: 1.25 hours
Psychology: 1.25 hours
Social Work: 1.25 hours - MOC Credit Details: ABS - 1.25 Point; Credit Type(s): Accredited CME (ABS)
- Commercial Support: Source: Intra-Cellular - Amount: 0 - Is Kind Support: False
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: No, it's free
- Measured Outcome: Learner Knowledge, Learner/Team Competence
- Provider Ship: Directly Provided
- Registration: Open to all
- Specialty: General Surgery
Subscribe
Login
0 Comments
Oldest